Cargando…

Cross design analysis of randomized and observational data – application to continuation rates for a contraceptive intra uterine device containing Levonorgestrel in adolescents and adults

BACKGROUND: To combine results from a randomized controlled study (RCT) and an observational study (OS) to evaluate discontinuation rate of a levonorgestrel-containing intrauterine contraceptive device (LNG IUD) in a real-life setting. METHODS: We included 253 parous and nulliparous women aged 21–40...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaitsiakhovich, Tatsiana, Filonenko, Anna, Lynen, Richard, Endrikat, Jan, Gerlinger, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230249/ https://www.ncbi.nlm.nih.gov/pubmed/30413199 http://dx.doi.org/10.1186/s12905-018-0674-1

Ejemplares similares

Cost‐effectiveness analysis of a low‐dose contraceptive levonorgestrel intrauterine system in Sweden
por: Henry, Nathaniel, et al.
Publicado: (2015)

Effects of the levonorgestrel-containing intrauterine device, copper intrauterine device, and levonorgestrel-containing oral contraceptive on susceptibility of immune cells from cervix, endometrium and blood to HIV-1 fusion measured ex vivo
por: Cavrois, Marielle, et al.
Publicado: (2019)

Uterine Perforation by Levonorgestrel-Releasing Intrauterine Device: A Case Report
por: Roman, Jose D
Publicado: (2022)

Safety, efficacy and patient satisfaction with continuous daily administration of levonorgestrel/ethinylestradiol oral contraceptives
por: Benagiano, Giuseppe, et al.
Publicado: (2009)

Non-contraceptive applications of the levonorgestrel intrauterine system
por: Rodriguez, Maria Isabel, et al.
Publicado: (2010)

Role of the levonorgestrel intrauterine system in effective contraception
por: Attia, Abdelhamid M, et al.
Publicado: (2013)

Levonorgestrel release rates measured through analysis of two-rod contraceptive explants
por: Fuchs, Rachael, et al.
Publicado: (2020)

Pregnancy rate after emergency contraception with single‐dose oral levonorgestrel in Japanese women
por: Sakurai, Shigeru
Publicado: (2019)

CASE REPORT: RETRIEVAL OF AN INTRA-UTERINE CONTRACEPTIVE DEVICE PENETRATING THROUGH THE WALL OF THE RECTUM
por: Bello, O.O, et al.
Publicado: (2018)

Apparent Rarity of Asymptomatic Herpes Cervicitis in a Woman with Intra-Uterine Contraceptive Device
por: Fowotade, Adeola, et al.
Publicado: (2013)

Association between knowledge about levonorgestrel emergency contraception and the risk of ectopic pregnancy following levonorgestrel emergency contraception failure: a comparative survey
por: Zhang, Duo, et al.
Publicado: (2016)

An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems
por: Janagam, Dileep R., et al.
Publicado: (2016)

Open surgical retrieval of intra-uterine contraceptive device perforating the ileum: A case report
por: Almatary, Abdullah, et al.
Publicado: (2023)

The New Extended-Cycle Levonorgestrel-Ethinyl Estradiol Oral Contraceptives
por: Bonnema, Rachel A., et al.
Publicado: (2011)

The Levonorgestrel Intrauterine System: A Pragmatic View of an Excellent Contraceptive
por: Jacobstein, Roy, et al.
Publicado: (2015)

Over-The-Counter Availability of Levonorgestrel Emergency Contraception in Pharmacies on Oahu
por: Chin, Jennifer, et al.
Publicado: (2020)

Patient acceptability, continuation and complication rates with immediate postpartum levonorgestrel intrauterine device insertion at caesarean section and vaginal birth
por: Wojcik, Natasha, et al.
Publicado: (2022)

Validation of a menstrual pictogram and a daily bleeding diary for assessment of uterine fibroid treatment efficacy in clinical studies
por: Haberland, Claudia, et al.
Publicado: (2020)

Gonadotropin Glycoforms Circulating in Women Using Progestins of the Levonorgestrel Family for Contraception
por: Eriksson, Karin, et al.
Publicado: (2020)

Levonorgestrel emergency contraception and bodyweight: are current recommendations consistent with historic data?
por: Kardos, László
Publicado: (2020)

Models and methods to characterise levonorgestrel release from intradermally administered contraceptives
por: Al Dalaty, Adnan, et al.
Publicado: (2021)

Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol‐containing oral contraceptive in healthy adult women
por: Trezza, Christine, et al.
Publicado: (2017)

Abnormal uterine bleeding in midlife: The role of levonorgestrel intrauterine system
por: Shawki, Osama, et al.
Publicado: (2013)

Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review
por: Sanders, Jessica N., et al.
Publicado: (2017)

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz
por: Carten, Monica L., et al.
Publicado: (2012)

Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives
por: Meece, Frederick A., et al.
Publicado: (2018)

Pattern recognition in menstrual bleeding diaries by statistical cluster analysis
por: Gerlinger, Christoph, et al.
Publicado: (2009)

Provider and lay perspectives on intra-uterine contraception: a global review
por: Daniele, Marina A. S., et al.
Publicado: (2017)

Depressive Disorder With Panic Attacks After Replacement of an Intrauterine Device Containing Levonorgestrel: A Case Report
por: Zeiss, René, et al.
Publicado: (2020)

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function
por: Ågren, Ulla M, et al.
Publicado: (2011)

The Cost-Effectiveness of Emergency Hormonal Contraception with Ulipristal Acetate versus Levonorgestrel for Minors in France
por: Schmid, Ramona
Publicado: (2015)

551. MK-8591 Does Not Alter the Pharmacokinetics of the Oral Contraceptives Ethinyl Estradiol and Levonorgestrel
por: Ankrom, Wendy, et al.
Publicado: (2018)

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System
por: Teal, Stephanie B., et al.
Publicado: (2019)

Levonorgestrel Microneedle Array Patch for Sustained Release Contraception: Formulation, Optimization and In Vivo Characterization
por: Rajput, Amarjitsing, et al.
Publicado: (2022)

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
por: Jick, Susan S, et al.
Publicado: (2011)

Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2019)

Treatment of menorrhagia due to aplastic anemia by hysteroscopic resection of endometrial functional layer and levonorgestrel-releasing intra-uterine system: Three case reports
por: Yang, Huadi, et al.
Publicado: (2019)

Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol compared with one containing levonorgestrel and ethinylestradiol on haemostasis, lipids and carbohydrate metabolism
por: Ågren, Ulla M, et al.
Publicado: (2011)

Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use
por: Miranda, Laura, et al.
Publicado: (2021)

An empirically generated responder definition for rosacea treatment
por: Staedtler, Gerald, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_09et9uloklm9f17bit1semspo7